Hsin–Wei Chen

6.1k total citations
133 papers, 5.0k citations indexed

About

Hsin–Wei Chen is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Hsin–Wei Chen has authored 133 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Immunology, 39 papers in Infectious Diseases and 25 papers in Molecular Biology. Recurrent topics in Hsin–Wei Chen's work include Immunotherapy and Immune Responses (35 papers), Mosquito-borne diseases and control (24 papers) and Viral Infections and Vectors (19 papers). Hsin–Wei Chen is often cited by papers focused on Immunotherapy and Immune Responses (35 papers), Mosquito-borne diseases and control (24 papers) and Viral Infections and Vectors (19 papers). Hsin–Wei Chen collaborates with scholars based in Taiwan, Japan and United States. Hsin–Wei Chen's co-authors include Kuo–Chuan Ho, Tsutomu Miyasaka, Chung‐Wei Kung, M. Ikegami, R. Vittal, Shih‐Jen Liu, Chia‐Yu Lin, Nobuya Sakai, Pele Chong and Chih‐Hsiang Leng and has published in prestigious journals such as Advanced Materials, ACS Nano and The Journal of Immunology.

In The Last Decade

Hsin–Wei Chen

130 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsin–Wei Chen Taiwan 39 1.6k 1.5k 1.1k 838 728 133 5.0k
Shihua Li China 36 967 0.6× 738 0.5× 719 0.7× 154 0.2× 256 0.4× 94 3.6k
Jae‐Wook Lee South Korea 42 1.2k 0.8× 2.0k 1.4× 687 0.6× 588 0.7× 273 0.4× 271 7.0k
Yujie Ma China 42 1.8k 1.1× 2.0k 1.4× 690 0.6× 671 0.8× 230 0.3× 195 6.3k
Hiroyuki Iwata Japan 33 580 0.4× 850 0.6× 249 0.2× 207 0.2× 194 0.3× 254 3.5k
Jing Huang China 42 506 0.3× 1.3k 0.9× 328 0.3× 234 0.3× 259 0.4× 104 5.9k
Yin Hu China 34 4.4k 2.7× 2.0k 1.3× 1.1k 1.0× 256 0.3× 511 0.7× 164 6.5k
Yuanxing Zhang China 33 1.5k 0.9× 355 0.2× 319 0.3× 204 0.2× 913 1.3× 118 3.5k
Iftikhar Hussain Hong Kong 57 5.0k 3.0× 3.5k 2.4× 1.9k 1.7× 939 1.1× 222 0.3× 309 9.2k
Noriko Saito Japan 33 1.2k 0.7× 1.6k 1.1× 249 0.2× 140 0.2× 132 0.2× 220 4.5k
Gregory N. Tew United States 63 1.5k 0.9× 2.2k 1.5× 376 0.4× 1.4k 1.7× 281 0.4× 224 12.4k

Countries citing papers authored by Hsin–Wei Chen

Since Specialization
Citations

This map shows the geographic impact of Hsin–Wei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsin–Wei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsin–Wei Chen more than expected).

Fields of papers citing papers by Hsin–Wei Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsin–Wei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsin–Wei Chen. The network helps show where Hsin–Wei Chen may publish in the future.

Co-authorship network of co-authors of Hsin–Wei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Hsin–Wei Chen. A scholar is included among the top collaborators of Hsin–Wei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsin–Wei Chen. Hsin–Wei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Wei‐Liang, et al.. (2024). Effect of C-type lectin 16 on dengue virus infection in Aedes aegypti salivary glands. PNAS Nexus. 3(5). pgae188–pgae188.
2.
Chiang, Chen-Yi, et al.. (2024). SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters. Journal of Virology. 98(2). e0154623–e0154623.
3.
Yen, Li-Chen, Hsin–Wei Chen, Chang-Chi Lin, et al.. (2023). Neutralizing antibodies targeting a novel epitope on envelope protein exhibited broad protection against flavivirus without risk of disease enhancement. Journal of Biomedical Science. 30(1). 41–41. 6 indexed citations
4.
Chen, Hsin–Wei, et al.. (2022). Comparative Adverse Kidney Outcomes in Women Receiving Raloxifene and Denosumab in a Real-World Setting. Biomedicines. 10(7). 1494–1494. 2 indexed citations
5.
Chen, Hsin–Wei, Shuying Wang, Chih‐Peng Chang, et al.. (2022). A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein. Vaccine. 40(15). 2299–2310. 3 indexed citations
6.
Chiang, Chen-Yi, Szu-Chia Lai, Chia-Yi Yu, et al.. (2022). Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants. JCI Insight. 7(8). 22 indexed citations
7.
Shen, Kuan‐Yin, Chung‐Hsiang Yang, Chiung‐Tong Chen, et al.. (2022). Omicron‐specific mRNA vaccine induced cross‐protective immunity against ancestral SARS‐CoV‐2 infection with low neutralizing antibodies. Journal of Medical Virology. 95(1). e28370–e28370. 10 indexed citations
9.
Chiang, Chen-Yi, et al.. (2021). A Novel Recombinant Fcγ Receptor-Targeted Survivin Combines with Chemotherapy for Efficient Cancer Treatment. Biomedicines. 9(7). 806–806. 5 indexed citations
10.
Shen, Kuan‐Yin, Mei‐Yu Chen, Guann‐Yi Yu, et al.. (2021). DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss. PLoS neglected tropical diseases. 15(5). e0009374–e0009374. 17 indexed citations
11.
Huang, Tse‐Hung, et al.. (2018). Locally Targeting the IL-17/IL-17RA Axis Reduced Tumor Growth in a Murine B16F10 Melanoma Model. Human Gene Therapy. 30(3). 273–285. 18 indexed citations
12.
Chiang, Chen-Yi, et al.. (2018). Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity. Frontiers in Immunology. 9. 822–822. 9 indexed citations
13.
Chen, Mei‐Yu, et al.. (2017). Detection and quantification of dengue virus using a novel biosensor system based on dengue NS3 protease activity. PLoS ONE. 12(11). e0188170–e0188170. 13 indexed citations
15.
Chiang, Chen-Yi, Chien-Hsiung Pan, Mei‐Yu Chen, et al.. (2016). Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice. Scientific Reports. 6(1). 30648–30648. 33 indexed citations
17.
Song, Ying, Hsueh‐Hung Liu, I‐Hua Chen, et al.. (2014). A Purified Recombinant Lipopeptide as Adjuvant for Cancer Immunotherapy. BioMed Research International. 2014. 1–10. 7 indexed citations
18.
Li, Hsin-Yang, Hsin–Wei Chen, Shih‐Hwa Chiou, et al.. (2011). Enhancement of Wound Healing by Human Multipotent Stromal Cell Conditioned Medium: The Paracrine Factors and p38 MAPK Activation. Cell Transplantation. 20(5). 693–706. 127 indexed citations
19.
Huang, Ming‐Hsi, Chiung‐Yi Huang, Ai‐Hsiang Chou, et al.. (2009). Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccine. Microbes and Infection. 11(6-7). 654–660. 15 indexed citations
20.
Chen, Hsin–Wei, et al.. (2008). Production Ratio of Nuclear Fallout 137Cs/135Cs. 46(5). 560. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026